Allstate Corp Biogen Inc. Transaction History

Allstate Corp

$1.2 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $666,189 - $809,434	2,639 Added 83.91%	5,784 $1.6 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $520,601 - $717,862	-2,674 Reduced 45.95%	3,145 $840,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $328,007 - $390,061	-1,749 Reduced 23.11%	5,819 $1.19 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1 Million - $1.27 Million	5,186 Added 217.72%	7,568 $1.59 Million
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $88,672 - $113,956	-396 Reduced 14.25%	2,382 $571,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $33,109 - $43,178	-117 Reduced 4.04%	2,778 $786,000
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $9,324 - $14,929	36 Added 1.26%	2,895 $1 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $77,015 - $90,227	317 Added 12.47%	2,859 $800,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $10,631 - $16,003	-45 Reduced 1.74%	2,542 $622,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $553,369 - $638,933	-2,090 Reduced 44.69%	2,587 $734,000
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $187,787 - $248,691	-726 Reduced 13.44%	4,677 $1.25 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $3.09 Million - $3.92 Million	-11,496 Reduced 68.03%	5,403 $1.71 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $266,712 - $368,532	1,212 Added 7.73%	16,899 $5.01 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $246,794 - $276,803	1,135 Added 7.8%	15,687 $3.65 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $277,621 - $306,017	-1,266 Reduced 8.0%	14,552 $3.4 Million
Q1 2019 May 20, 2019	BUY	$216.71 - $338.96 $88,200 - $137,956	407 Added 2.64%	15,818 $3.74 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $4.29 Million - $5.44 Million	15,411 New	15,411 $4.64 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Account